In Peer Reviewed Journals
Altman DG, Ohuma EO; The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Statistical considerations for the development of prescriptive fetal and newborn growth standards in the INTERGROWTH-21st Project. BJOG 2013 May 17 [Epub ahead of print]
Bala MM, Akl EA, Sun X, Bassler D, Mertz D, Mejza F, Vandvik PO, Malaga G, Johnston BC, Dahm P, Alonso-Coello P, Diaz-Granados N, Srinathan SK, Hassouneh B, Briel M, Busse JW, You JJ, Walter SD, Altman DG, Guyatt GH. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis. J Clin Epidemiol 2013; 66: 286-295.
Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts.PLoS Med 2013; 10: e1001419.
Birks J, McGuinness B, Craig D. Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev 2013; 5: CD004744.
Burns T, Rugkåsa J, Molodynski A, Dawson J, Yeeles K, Vazquez-Montes M,Voysey M, Sinclair J, Priebe S. Community treatment orders for patients with psychosis (OCTET): a randomized controlled trial. Lancet 2013; 381: 1627-1633.
Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev 2013; (3): CD009072.
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013; 309: 814-822.
Chalmers I, Altman DG, McHaffie H, Owens N, Cooke RWI. Data sharing among data monitoring committees and responsibilities to patients and science.Trials 2013; 14: 102.
Chan AW, Tetzlaff J, Altman DG, Dickersin K, Moher D. SPIRIT 2013: New guidance for content of clinical trial protocols. Lancet 2013; 381: 91-92.
Chan AW, Tetzlaff J, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hròbjartsson A, Mann H, Dickersin K, Berlin JA, Doré C, Parulekar W, Summerskill W, Groves T, Schulz KF, Sox H, Rockhold FW, Dubois-Flynn G, Rennie D, Moher D. SPIRIT 2013 Statement: Defining standard protocol items for clinical trials. Ann Intern Med 2013; 158: 200-207.
Chan AW, Tetzlaff J, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hròbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013; 346: e7586.
Collins GS. Cardiovascular disease risk prediction in the UK. Prim Care Cardiovasc J 2013 [Epub ahead of print].
Collins GS. Reply to a systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol 2013 [Epub ahead of print].
Collins GS, Altman DG. Calibration of EuroSCORE II. Eur J Cardiothorac Surg 2013; 43: 654.
Collins GS, Altman DG. Identifying patients with suspected gastro-oesophageal cancer in primary care: external validation of QCANCER® (Gastro-Oesophageal). Eur J Cancer 2013; 49: 1040-1048.
Collins GS, Altman DG. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCANCER®(renal) prediction model. Cancer Epidemiol 2013; 37: 115-120.
Collins GS, Le Manach Y. Multivariable risk prediction models: it's all about the performance. Anesthesiology 2013; 118: 1252-1253.
Collins GS, Omar O, Shanyinde M, Yu LM. A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol 2013; 66: 268-277.
Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress IR, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 2013 May 30 [Epub ahead of print].
Cottone F, Efficace F, Apolone G, Collins GS. The added value of propensity score matching when using health-related quality of life reference data. Stat Med 2013 [Epub ahead of print].
Flodgren G, Conterno LO, Mayhew A, Omar O, Pereira CR, Shepperd S.Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev 2013; (3): CD006559.
Groenwold RHH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KGM. Adjustment for continuous confounders: an example of how to prevent residual confounding. CMAJ 2013; 185: 401-406.
Hemingway H, Croft P, Perel PA, Hayden JA, Abrams K, Timmis AD, Briggs A, Udumyan R, Moons KGM, Steyerberg EW, Roberts IG, Schroter S, Altman DG, Riley RD for the PROGRESS Group. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes. BMJ 2013; 346: e5595.
Hingorani A, van der Windt DA, Riley RD, Abrams K, Moons KGM, Steyerberg EW, Schroter S, Sauerbrei W, Altman DG, Hemingway H for the PROGRESS Group. Prognosis research strategy (PROGRESS) 4: Stratified medicine research. BMJ 2013; 346: e5793.
Hopewell S, Omar O, Hyde C, Yu LM, Doree C, Murphy MF. A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010. BMJ Open2013; 3: e002154.
Hrobjartsson A, Boutron I, Turner L, Altman DG, Moher D. Assessing risk of bias in randomized clinical trials included in Cochrane reviews: the why is easy, the how is a challenge. Cochrane Database Syst Rev 2013; 5: ED000058.
Huijbers A, Tollenaar RA, v Pelt GW, Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit VT, Midgley R, Warren BF, Johnstone EC, Kerr DJ, Mesker WE. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 2013; 24: 179-185.
Karamitsos TD, Dass S, Suttie J, Sever E, Birks J, Holloway CJ, Robson MD, Jerosch-Herold M, Watkins H, Neubauer S. Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2013; 61: 1169-1176.
Khatami A, Snape MD, Ohene-Kena B, Young K, Oeser C, Michaelis LJ, Macleod E, Smee H, Van Der Meeren O, Leyssen M, Caubet M, Yu LM, Heath PT, Faust SN, Finn A, Pollard AJ. Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants. Pediatr Infect Dis J 2013 Jan 23. [Epub ahead of print]
Kotecha D, Manzano L, Altman DG, Krum H, Erdem G, Williams N, Flather MD, Beta-Blockers in Heart Failure Collaborative Group. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design. Syst Rev2013; 2: 7.
Kreckler S, Morgan RD, Catchpole K, New S, Handa A, Collins G, McCulloch P. Effective prevention of thromboembolic complications in emergency surgery patients using a quality improvement approach. BMJ Qual Saf 2013 May 24 [Epub ahead of print].
Lang TA, Altman DG. Basic statistical reporting for articles published in clinical medical journals: the SAMPL Guidelines. In: Smart P, Maisonneuve H, Polderman A (eds). Science Editors’ Handbook. European Association of Science Editors, 2013.
Molyneux A, Kerr R, Birks J. Editorial: Barrow Ruptured Aneurysm Trial. J Neurosurg 2013 Apr 26. [Epub ahead of print]
Ohuma EO, Hoch L, Cosgrove C, Knight HE, Cheikh Ismail L, Juodvirsiene L, Papageorghiou AT, Al-Jabri H, Domingues M, Gilli P, Kunnawar N, Musee N, Roseman F, Carter A, Wu M, Altman DG, the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Managing data for the international, multicentre INTERGROWTH-21st Project. BJOG 2013 May 17 [Epub ahead of print]
Phillips P, Boone D, Mallett S, Taylor SA, Altman DG, Manning D, Gale A, Halligan S. Method for tracking eye gaze during interpretation of endoluminal 3D CT Colonography: Technical description and proposed metrics for analysis.Radiology 2013 Feb 4. [Epub ahead of print]
Pocock SJ, Piaggio G, Altman DG. Reporting noninferiority trials - reply.JAMA 2013; 309: 1575.
Rashidi BH, Nemati M, Ghazizadeh M, Salem SA, Collins GS, Sills ES. Teaching reproductive endocrinology in Iran: pilot assessment of hospital-based clinical modules for medical students at Tehran University of Medical Sciences. Health 2013; 5: 175-178.
Riley RD, Hayden JA, Steyerberg EW, Moons KGM, Abrams K, Kyzas PA, Malats N, Briggs A, Schroter S, Altman DG, Hemingway H for the PROGRESS Group. Prognosis research strategy (PROGRESS) 2: Prognostic factor research. PLoS Med 2013; 10: e1001380.
Royston P, Altman DG. External validation of cox prognostic model: principles and methods. BMC Med Res Methodol 2013; 13: 33.
Rowland R, Pathan AA, Satti ID, Matsumiya MM, Whittaker M, Minassian AM, O’Hara GA, Hamill M, Scott JT, Harris SA, Poyntz HC, Bateman C, Meyer J,Williams N, Gilbert SC, Lawrie AM, Hill AV, McShane H. Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial. Hum Vaccin Immunother 2013; 9: 50-62.
Sarris I, Ohuma E, Ioannou C, Sande J, Altman DG, Papageorghiou AT, on behalf of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Fetal biometry: how well can offline measurements from 3D volumes substitute real time 2D measurements?Ultrasound Obstet Gynecol 2013 Jan 17 [Epub ahead of print].
Sills ES, Collins GS. Preterm births in countries with a very high human development index. Lancet 2013; 381: 1355-1356.
Simera I, Altman DG. Reporting medical research. Int J Clin Pract 2013; May 9 [Epub ahead of print].
Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Hum Reprod Update 2013; 19: 105-123.
Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG for the PROGRESS Group. Prognosis research strategy (PROGRESS) 3: Prognostic model research. PLoS Med 2013; 10: e1001381.
Swann R, Perkins KA, Velentzis LS, Ciria C, Dutton SJ, Mulligan AA, Woodside JV, Cantwell MM, Leathem AJ, Robertson CE, Dwek MV. The DietCompLyf study: A prospective cohort study of breast cancer survival and phytoestrogen consumption. Maturitas 2013 May 7. [Epub ahead of print]
Villar J, Altman DG, Purwar M, Noble JA, Knight HE, Ruyan P, Cheikh Ismail L, Barros FC, Lambert A, Papageorghiou AT, Carvalho M, Jaffer YA, Bertino E, Gravett MG, Bhutta ZA, Kennedy SH; the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). The objectives, design and implementation of the INTERGROWTH-21st Project.BJOG 2013 May 17 [Epub ahead of print]
Walsh APH, Collins GS, Walsh DJ, Shkrobot LV, Malone FD, Sills ES. Medical student experiences in clinical reproductive medicine: dual-cohort assessment of a new learning module at the Royal College of Surgeons. Br J Med Med Res2013; 3: 466-473.
Yates TA, Paranthaman K, Yu LM, Davis E, Lang S, Hackett SJ, Welch SB, Pollard AJ, Snape MD. UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure. Arch Dis Child 2013; 98: 429-433.